EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Intravitreal injection of ranibizumab with and without prior anterior chamber paracentesis in diabetic macular oedema using optical coherence tomography angiography

Amr M. Sanad, Moataz M. Wessam, Mohamed I. Saleh, Amr I. Elawamry, Tamer M. Elraggal

Journal of the Egyptian Ophthalmological Society · 2026-04 · 119 (2) · 209-214

DOI: 10.4103/ejos.ejos_73_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Egyptian Ophthalmological Society, online erschienen am 13.04.2026. Verfasst von Amr M. Sanad und 4 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intravitreal injections (IVI) of anti-VEGF agents are the gold standard for treatment of diabetic macular edema (DME), but they cause acute intraocular pressure (IOP) spikes that may affect retinal microvasculature. Anterior chamber paracentesis (ACP) can prevent these IOP elevations.

Aim

To assess the effects of transient changes in IOP on retinal microvasculature using optical coherence tomography angiography macular and peripapillary vessel density (VD), highlighting the role of ACP before IVI of Ranibizumab on retinal microvasculature in patients with DME. Settings and design A prospective comparative interventional study conducted in the Ophthalmology department of Ain Shams University Hospital between October 2022 and March 2024. Patients and methods This study included 102 eyes with nonischemic diffuse center-involving DME. Eyes were randomized into two groups: group A (51 eyes) received intravitreal ranibizumab without prior ACP, and Group B (51 eyes) received intravitreal ranibizumab with prior ACP. Optical coherence tomography angiography was performed to measure VD parameters in macular and peripapillary regions pre-operatively, immediately postoperatively, and on the first postoperative day.

Results

The mean change in IOP (ΔIOP) from baseline was +12.0±3.4 mmHg in group A (without ACP) and −5.2±1.8 mmHg in group B (with ACP), demonstrating a significant difference between the two groups. Immediate postoperative superficial and deep vessel densities were significantly reduced in group A compared with group B. Disc angiographic parameters showed pronounced transient decrease in group A but remained stable in group B. Although partial recovery occurred by the first day, VD parameters in group A remained below preoperative levels.

Conclusion

Prophylactic ACP effectively prevents acute IOP-related effects on retinal microvasculature during intravitreal ranibizumab injection. These findings support the routine use of ACP to enhance the safety profile of intravitreal therapy in DME management.

Zitieren

APA

Sanad, A. M., Wessam, M. M., Saleh, M. I., Elawamry, A. I., & Elraggal, T. M. (2026). Intravitreal injection of ranibizumab with and without prior anterior chamber paracentesis in diabetic macular oedema using optical coherence tomography angiography. Journal of the Egyptian Ophthalmological Society, 119(2), 209-214. https://doi.org/10.4103/ejos.ejos_73_25

Vancouver

Sanad AM, Wessam MM, Saleh MI, Elawamry AI, Elraggal TM. Intravitreal injection of ranibizumab with and without prior anterior chamber paracentesis in diabetic macular oedema using optical coherence tomography angiography. Journal of the Egyptian Ophthalmological Society. 2026;119(2):209-214. doi:10.4103/ejos.ejos_73_25

BibTeX
@article{Sanad2026,
  author = {Sanad, Amr M. and Wessam, Moataz M. and Saleh, Mohamed I. and Elawamry, Amr I. and Elraggal, Tamer M.},
  title = {Intravitreal injection of ranibizumab with and without prior anterior chamber paracentesis in diabetic macular oedema using optical coherence tomography angiography},
  journal = {Journal of the Egyptian Ophthalmological Society},
  year = {2026},
  volume = {119},
  number = {2},
  pages = {209--214},
  doi = {10.4103/ejos.ejos_73_25}
}
Kostenlos starten →